Medication Efficacy in Personalized Medicine

Pharmacolog specialize in efficient solutions to prevent medication errors and to simplify the reconstitution and compounding process of medical drugs. With our safety device DrugLog®, you can quickly verify that the intravenous medication is accurate before it’s given to the patient. ReVal™ is an application that provides an assisted workflow when preparing pharmaceuticals in pediatric care.

News

Pharmacolog offentliggör prospekt avseend...

INFORMATIONEN I DETTA PRESSMEDDELANDE FÅR INTE OFFENTLIGGÖRAS, PUBLICERAS ELLER DISTRIBUERAS, DIREKT ELLER INDIREKT, TILL ...

Read more

Pharmacolog genomför företrädesemission...

INFORMATIONEN I DETTA PRESSMEDDELANDE FÅR INTE OFFENTLIGGÖRAS, PUBLICERAS ELLER DISTRIBUERAS, DIREKT ELLER INDIREKT, TILL ...

Read more

Kommuniké från extra bolagsstämma i Pha...

Aktieägarna i Pharmacolog i Uppsala AB (publ) höll extra bolagsstämma den 25 april 2018 i Uppsala och beslutade om följand...

Read more
See all »

Events

12 th NOBOS conference, 1-5 June, 2018, Vi...

NOBOS/NOPHOS (Nordic Society of Pediatric Oncology Nurses) is a society for nurses working with pediatric oncology in Denm...

Read more
See all »

Blog

New technology may stem the tide of opioid...

Opioid abuse is reaching levels so alarming that United States authorities have declared it a national public health emerg...

Read more

”I think everyone agrees that the medica...

Hello Kent Öbrink! Could you tell us a bit about your background, and how you got started at Pharmacolog?

I have wo...

Read more

Cultivating safety: Save lives, save money

Professional errors are unavoidable, particularly in high-stakes, high-pressure environments such as hospitals. When caret...

Read more
See all »

The Company

Pharmacolog AB is a medical device company based in Uppsala, Sweden. The company specializes in providing quality assurance solutions for safe administration of medical drugs. The company was established in 2007 by Hans Dahlin and the late Kjell Westerlund.

The long term vision for the company is to play an active role in developing treatment methods for patients with cancer and other fatal diseases.